Ligand-dependent down-regulation of the glucocorticoid receptor (GR) has be
en shown to limit hormone responsiveness, but the mechanisms involved in th
is process are poorly understood. The glucocorticoid receptor is a phosphop
rotein that upon ligand binding becomes hyperphosphorylated, and recent evi
dence indicates that phosphorylation status of the glucocorticoid receptor
plays a prominent role in receptor protein turnover. Because phosphorylatio
n is a key signal for ubiquitination and proteasomal catabolism of many pro
teins, we evaluated whether the ubiquitin-proteasomal pathway had a role in
glucocorticoid receptor down-regulation and the subsequent transcriptional
response to glucocorticoids. Pretreatment of COS-1 cells expressing mouse
glucocorticoid receptor with the proteasome inhibitor MG-132 effectively bl
ocks glucocorticoid receptor protein down-regulation by the glucocorticoid
dexamethasone. Interestingly, both MG-132 and a second proteasome inhibitor
beta -lactone significantly enhanced hormone response of transfected mouse
glucocorticoid receptor toward transcriptional activation of glucocorticoi
d receptor-mediated reporter gene expression. The transcriptional activity
of the endogenous human glucocorticoid receptor in HeLa cells was also enha
nced by MG-132. Direct evidence for ubiquitination of the glucocorticoid re
ceptor was obtained by immunoprecipitation of cellular extracts from protea
some-impaired cells. Examination of the primary sequence of mouse, hu man,
and rat glucocorticoid receptor has identified a candidate PEST degradation
motif. Mutation of Lys-426 within this PEST element both abrogated ligand-
dependent down-regulation of glucocorticoid receptor protein and simultaneo
usly enhanced glucocorticoid receptor-induced transcriptional activation of
gene expression. Unlike wild type GR, proteasomal inhibition failed to enh
ance significantly transcriptional activity of K426A mutant GR. Together th
ese findings suggest a major role of the ubiquitin-proteasome pathway in re
gulating glucocorticoid receptor protein turnover, thereby providing a mech
anism to terminate glucocorticoid responses.